Showing 411 - 420 of 524 for "Luxembourg" with applied filters
25 March 2019 by
In mid-January 2019, GSK Stockmann advised on Germany’s first-ever issuance of securities originally carried out as a blockchain transaction. Commerzbank AG, Continental AG and Siemens AG were involved in the transaction.
01 March 2019 by
2018 has once again shown a growing trend in M&A transactions with a view to Luxembourg-based target entities as well as acquisitions outside of Luxembourg that were started using a Luxembourg structure. Luxembourg-based targets are typically not the centre of high-profile M&A targets.
21 January 2019 by
BRIEFING: Luxembourg, 21 January, 2019
21 January 2019 by
BRIEFING: Luxembourg, 21 January, 2019
04 January 2019 by
GSK Stockmann’s Luxembourg office has advised China Merchants Bank (CMB) on its launch of CMB Evergreen SA, SICAV-SIF, a Luxembourg investment fund and being the first European-based investment fund of CMB.
03 January 2019 by
BRIEFING: Limassol, 3 January, 2019
19 December 2018 by
IFLR 2018 M&A Report: Luxembourg
12 December 2018 by
At the end of November 2018, GSK Stockmann’s Partners elected Andreas Heinzmann as International Partner and Dr. Uwe Jäger as new co-Managing Partner. These nominations underpin GSK’s commitment to internationaliza-tion and the consistent implementation of the modernization course the firm set out on.
09 October 2018 by
The Chinese Outbound Investment Guide 2018 has been published by International Financial Law Review (IFLR) and looks at the changes that have been occurring in Chinese outbound investment patterns and how target markets are adapting.
13 September 2018 by
The joint venture of a Starwood Capital Group fund subsidiary and CELLS Property Investors bought the Fifty Avon office buildings in downtown Frank-furt in a share deal. GSK Stockmann provided the legal support for this trans-action. The parties agreed to keep the purchase price confidential.